A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day − 1 ) for 4 days, increasing gradually to 2 day − 1 at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line.
Introduction
The evidence that cell death in bioreactors was via apoptosis was provided by Al-Rubeai et al. 1 from an electron microscopic study of hybridoma cells in batch cultures. The cellular ultra-structure of dead cells clearly showed the morphology of apoptosis, exhibiting evidence of chromatin condensation, disappearance of microvilli and intensive blebbing. Franek and Dolnikova 2 provided further evidence of apoptosis in the bioreactor environment when they showed the presence of nucleosomes in the supernatant of hybridoma cells cultured in protein free medium. More recently other industrially important cell line such as myeloma 3, 4 and CHO 5 have been screened and also found to be susceptible to apoptosis.
The batch mode of animal cell culture has several disadvantages, which include low cell density and low productivity. To enhance productivity, various methods using fed batch and perfusion have been developed. Perfusion culture is operated by retaining cells in the vessel whilst removing spent medium that contains the product and supplying fresh medium continuously. Various systems for cell retention have been developed including membrane filtration systems, dialysis reactors, devices using gravitational settling, the ultra sonic and the spin filters. 6 The spin filter method used in the present study has been widely reported by other investigators. [7] [8] [9] [10] [11] [12] [13] This system allows one to reach many times the cell density of batch culture. However, the high cell density and insufficient mixing results in the unequal distribution of nutrients and oxygen. Cells within the bioreactor may be subjected to nutrient deprivation, and/or hyper-and hypoxic conditions, all of which have been reported to be potent apoptotic inducers. 3, 4, 14, 15 Indeed, apoptosis has been identified as the major caused of cell death of hybridoma 9, 16 and myeloma 17 cells in perfusion culture. Over-expression of Bcl-2 9 and E1B-19K 17 proteins in hybridoma and myeloma cells has been reported to effectively suppress apoptotic death in the hostile environment of perfusion cultures.
The bcl-2 is a proto-oncogene 18 encodes a 27 kDa transmembrane protein, which is confined to long-lived or proliferating adult cells such as B-cells. The majority of reported results showed that Bcl-2 over-expression does significantly suppress the apoptosis for a number of industrially important cell lines. 9, 15, [19] [20] [21] [22] [23] [24] [25] [26] [27] However, its effect on antibody productivity is not consistent. Itoh et al. 19 and Simpson et al. 15 showed that Bcl-2 over-expression resulted in a substantial increase in final antibody titre in serum-supplemented batch cultures. The results of other researchers showed that there was no significant improvement of antibody productivity for bcl-2 transfected cell lines in batch cultures of hybridoma 24 and NS0 26 and CHO 27 cells. However, when the bcl-2 transfected NS0 cells were fed with concentrated amino acids, a substantial increase in antibody titres was recorded. 26 Bierau et al. 9 showed that the antibody productivity of bcl-2 transfected hybridoma was lower compared to its control counterpart in high cell density perfusion culture. However, in another study, Fassnacht et al. 25 reported Bcl-2 over-expression has substantially increased the antibody productivity in hybridoma high cell density perfusion culture. These inconsistent results showed that an increase in the longevity of cells is not necessarily a comprehensive solution to antibody productivity improvement. Furthermore, in chemostat cultures of hybridoma cells, the enhanced robustness of the bcl-2 transfected cells did not bring any improvement to antibody productivity at low dilution rate. 
Material and methods

Reactor description
A standard 2 litres glass bioreactor (inner diameter 105 mm, height 260 mm) with 1 litre working volume equipped with a spin filter was used (The LSL Group, Luton, UK). A diagram of the spin filter perfusion system is shown in Figure 1 . The diameter of the spin filter was 40 mm and a height of 90 mm. Its nominal pore size is 25 µm where it was immersed 50 mm inside the culture medium during fermentation. A top driven, 4-blade Rushton turbine impeller rotating at 110 rpm was used to provide mixing. Bubble free aeration was achieved by using an immersed silicone tubing (inner diameter 3.2 mm, wall thickness 0.8 mm) wound around the spin filter in a steel casing in a length of 3 m as shown in the Figure 1 . The dissolved oxygen was controlled at 50% air saturation by a gas flow controller (Brooks Instruments) with on-off valves for blending air, pure oxygen and nitrogen flows. The pH was controlled at 6.9 by automatic addition of CO 2 or base (0.2 M NaOH). The temperature of the bioreactor was controlled at 37
• C.
Cell line and culture conditions
The parent cell line NS0 6A1 was kindly supplied by LONZA Biologics (Slough, UK) and had previously been transfected with the glutamine synthetase (GS) expression system carrying a gene for a human-mouse chimeric antibody (cB72.3). The cells were transfected either with the bcl-2 gene (NS0 Bcl-2) or the negative transfection vector, which gives the control cell line (NS0 Control) as previously described. 26 The NS0 Bcl-2 cell line overexpresses the 'anti-apoptotic' human Bcl-2 protein. Cells were maintained in GMEM medium (Gibco, Paisely, UK) supplemented with 7.5% foetal calf serum (FCS) (Gibco, Paisley, UK), MEM non-essential amino acids (Gibco, Paisley, UK), 1 mM sodium pyruvate (Gibco, Paisely, UK), 500 µM glutamic acid, 500 µM asparagine, 30 µM adenosine, 30 µM guanosine, 30 µM cytidine, 30 µM uridine, 10 µM thymidine, 2.7 g L − 1 sodium bicarbonate and 100 µM methylionine sulphoximine (MSX) (all chemicals from Sigma, Poole, UK).
Cell count
Cell concentration was determined by haemocytometer count (improved Neubauer-Haemocytometer), and the trypan blue exclusion method was used to distinguish viable from non-viable cells.
Fluorescence microscopy: acridine orange-propidium iodide staining
This method was used in addition to the trypan blue staining method in order to determine the distributions of viable, early apoptotic, late apoptotic, necrotic and ghost cells. Each cell suspension sample was mixed with an equal volume of staining solution containing 10 mg ml − 1 acridine orange (AO) and 10 mg ml − 1 propidium iodide (PI). The mixture was loaded into an improved Neubauer rhodium-coated haemocytometer and cell numbers determined under fluorescence microscopy (excitation by UV light). By examination of colour and chromatin morphology the cells were classified and the results expressed as percentages of the total cells. Cells that exclude PI appeared green. If such cells showed a diffuse chromatin they were counted as viable cells. Otherwise, if their chromatin was condensed they were scored as early apoptotic cells. Red cells included PI and were counted as late apoptotic if their chromatin was condensed or as necrotic if they showed a diffuse chromatin. Chromatin free cells were counted as ghost. 26 
Quantification of IgG by ELISA
An enzyme-linked immunosorbent assay (ELISA) was developed to determine the concentration of the humanmouse chimeric cB72.3 IgG4 antibody (Mab) in the supernatants. Plates were coated with monoclonal anti-human IgG (Fcspecific, Sigma, Poole, UK) overnight at 4
• C. The wells were washed with 0.05% Tween 20 in 10 mM phosphate buffered saline (PBS) solution (PBS-T), and after blocking with 1% non fat milk, samples were incubated for 2 h at room temperature. After three washings the plates were incubated for 2 h at room temperature with peroxidase-conjugated antihuman-light chain antibody (Sigma Chemical Co., St. Louis, MO). The reaction was revealed with 0.05% o -phenylenediamine and 0.015% H 2 O 2 , and it was stopped with 1.25 M H 2 SO 4 . The absorbance was measured using a 492-nm filter. The concentration in each sample was calculated from a standard antibody curve.
Glucose determinations
Glucose in the culture supernatant was determined each day of the experiment using an enzymatic test kit (Glucose:GOD-Perid R Method, BOEHRINGER MANNHEIM).
Cell cycle analysis
Dead cells were removed from the analysis by incubation of cells in a 0.5 mg/ml DNase solution for 15 minutes at 37
• C. The cells were then washed in PBS and fixed in 70% ice-cold ethanol at a cell number of 10 6 ml − 1 and stored at 4
• C. Prior to analysis, cells were washed twice with PBS and resuspended in 500 µl of RNase solution and incubated for 20 minutes at 37
• C. Cells were again washed twice in PBS solution and resuspended in 1 ml PBS containing 50 µg ml − 1 propidium iodide solution (Sigma, UK). Cells were analysed using a Coulter Epics Elite flow cytometer. Single viable cells were selected by means of dual multi-parameter analysis of peak height and integral of fluorescence. 28 Cell cycle distributions were analysed using the Multicycle software package (Phoenix Flow Systems).
Calculations
Specific consumption rates
A specific substrate consumption rate can be obtained from the material balance as follows:
where V is the culture volume; S i , S o are the concentration of substrate (inlet/outlet stream); F i and F o are the inlet and outlet flow rate; and r s is the consumption rate.
The culture volume of the reactor was kept constant; therefore Eq. (1) can be written as:
Rearranged in terms of the consumption rate this gives the following:
To obtain the specific consumption rate, r s has to be divided by the viable cell concentration:
where r s ,sp is the specific consumption rate; x vt is the average viable cell concentration in time interval t 2 − t 1 ; S 1 , S 2 are the substrate concentrations at times t 1 and
Specific production rate
A specific antibody production rate can be obtained from the material balance as follows:
where V is the culture volume; P i ,P o are the concentration of product (inlet/outlet stream); F i and F o are the inlet and outlet flow rate; and r p is the production rate. The culture volume of the reactor was kept constant and there is no product in the inlet stream and perfusion rate; therefore Eq. (5) can be written as:
Rearranged in terms of the production rate this gives the following:
To obtain the specific production rate, r p has to be divided by the viable cell concentration:
where r p ,sp is the specific production rate; x vt is the average viable cell concentration in time interval t 2 − t 1 ; P 1 and P 2 are the product concentrations at times t 1 and t 2 ; d P ≈ P = P 2 − P 1 ; d t ≈ t = t 2 − t 1 .D and P o , were taken to be the mean values between time interval t 2 − t 1 .
Specific growth and death rates
A specific growth and death rate can be obtained from the material balance as follows:
Mass balance for viable cell:
and mass balance for death cells:
where V is the culture volume; x vi , x vo are the viable cell concentration (inlet/outlet stream); x di , x do are the dead cell concentration (inlet/outlet stream); F i and F o are the inlet and outlet flow rate; and r v , r d is the growth and death rate. The culture volume of the reactor was kept constant level and with a sterile feed, cell concentration in the outlet were very low compared to those in the reactor; therefore Eqs. (9) and (10) can be written as:
and
To obtain the specific death rate, r d has to be divided by the viable cell concentration:
where x vt is the average viable cell concentration in time interval t 2 − t 1 ; x d 1 , x d 2 are the dead cell concentrations at times t 1 and
Substituting k d into Eq. (11), the specific growth rate, µ = 1 x vt r v now can be rewritten as:
Experimental work
Stock cultures of NS0 Bcl-2 and control cell lines were established as for batch culture. At mid-exponential phase of the culture, cells were harvested by centrifugation and inoculated into the bioreactor in 1 litre fresh medium at a cell number of around 2 × 10 5 ml − 1 . On day 2, GMEM medium (GIBCO) (as per Section 2.1.2) supplemented with 0.5× MEM amino acids (GIBCO), 7.5% v/v FBS (GIBCO) and 100 Units/0.1 mg . ml − 1 penicillin/streptomycin (GIBCO) was continuously fed into the reactor via a calibrated peristaltic pumps (Watson-Marlow 101U, 4rpm max). The medium was contained in a 5 litre reservoir that was kept in an ice bath. The culture volume was controlled at 1 litre by using the other peristaltic pump to pump out the spent medium inside the spin filter into a 10 litre vessel. The perfusion rates used were 0.25, 0.5, 1.0, 1.5 and 2.0 day − 1 . Samples were taken daily in order to assess viable cell number, viability, glucose concentration, cell cycle phase, apoptosis levels and antibody titre as described above. Most of these parameters were analysed in replicates.
Results and discussions
The NS0 6A1 cells were initially cultivated in batch mode with a starting viable cell density of 3.6 × 10 5 cell/ml. The viable cell density of the Bcl-2 cell line after two days of batch culture was 8.93 × 10 5 cell/ml, which was about 6% higher than that found for the control cell line. Thereafter, the cultures were perfused with fresh medium at 0.5 volumes per day (day − 1 ) for 4 days, 1.0 day − 1 for 3 days, 1.5 day − 1 for 2 days and finally 2.0 day − 1 . The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell density of Bcl-2 culture was 2.3 × 10 6 , 5.26 × 10 6 , 7.12 × 10 6 and 1.50 × 10 7 cell/ml for 0.5, 1.0, 1.5 and 2.0 day − 1 respectively, which was 30%, 120%, 160% and 220% higher than its control cell line corresponding value (Figure 2a) . Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The growth rate of the Bcl-2 culture was slightly higher than that of the control culture (Figure 2c ). However, the death rate of the Bcl-2 culture was very much lower than the control culture (Figure 2d ). This can be seen from the viability of the control culture, which fell below 90% from day 6 onward to 69% when the culture was terminated. In contrast, the viability of Bcl-2 culture always remained above 90% throughout the culture and only dropped to 83% at day 17 before the culture was terminated (Figure 2b) .
The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture (Figure 3b) . From this point onward, the viable cell density of the Bcl-2 culture increased dramatically relative to that of the control culture. The level of necrosis remained at around 10% from day 6 until the end of the control culture. Interestingly, this low level of necrotic cells has also been observed under static and suspension batch cultures, and fed batch culture 26 of the control cell line but not in the Bcl-2 cultures. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) until day 12 (Figure 3a) . Necrosis in the Bcl-2 culture appeared following the decrease in glucose level (Figures 3a and 5a ). The drop in glucose level may also reflect the limitation of other nutrients such as amino acids. Therefore, necrosis in Bcl-2 cells may result from the limitation of essential nutrients.
Apoptosis has been identified as the major caused of cell death of hybridoma 9 and myeloma (Plasmocytoma) 4, 17 cells in perfusion culture. Over-expression of Bcl-2 9,25 and E1B-19K 17 proteins has been reported to effectively suppress apoptotic death in the hostile environment of perfusion cultures. In the present study, apoptotic death contributed to more than 65% of the cell death during the late stages of the control NS0 perfusion culture ( Figure 3b) . As in the suspension batch culture, there were still significant levels (about 10%) of necrotic cell death throughout the control perfusion culture. Interestingly, there were very few necrotic cells in the early stages of Bcl-2 perfusion culture, and they only appeared at the very late stages of the culture (Figure 3a) when the glucose level was decreased (Figures 3a and 5a ). Apoptotic cells were almost undetectable throughout the Bcl-2 perfusion culture. This suppression of apoptotic death by Bcl-2 protein in CHO 27 , NS0 26 cells and hybridoma cells 15 has also led to a delayed induction of necrosis. All these observations provide support to the suggestion by Kroemer et al. 30 that apoptosis and necrosis constitute two extremes of a continuum. 31 Suppression of apoptotic death by Bcl-2 overexpression in NS0 cells during the perfusion culture resulted in a more than 3-fold increase in viable cell density. Similarly, previous studies have found 2 to 2.6 fold increase in viability of a bcl-2 transfected hybridoma, 9,25 and E1B-19K transfected NS0 17 in perfusion cultures compared to their respective control cultures.
The trend of cell cycle distributions of the perfusion culture for both cell lines are very much similar as shown in Figure 4 , although generally Bcl-2 cell populations showed more S-phase cells than in the control populations. The specific glucose utilisation rate for the control culture was always higher than that for the Bcl-2 cell line (Figure 5b) . This indicated that the Bcl-2 cells were more efficient at utilising glucose than the control culture. Simpson et al. 22 has reported similar observations on amino acid consumption of bcl-2 transfected hybridoma cells. This finding together with that of Ishaqe and Al-Rubeai 32, 33 indicates a higher efficiency utilization of nutrients by the Bcl-2 cells.
The reported results of antibody productivity of bcl-2 transfected cell lines in high cell density perfusion culture are inconsistent. Bierau et al. 9 has reported a reduction in antibody productivity of a bcl-2 transfected hybridoma cell line. By contrast, Fassnacht et al. 25 reported a substantial increase in antibody productivity for the bcl-2 transfected cell line compared to the control cell line. In the present study, the increase in viable cell density (Figure 1a ) of the bcl-2 transfected cells did not lead to a similar increase in antibody titres (Figure 5c) .
The low specific cell antibody production rate in the Bcl-2 cell line may be explained by mass balance. Both cell lines were supplied with equal amounts of nutrients and their nutrient (e.g. glucose) consumption is very similar (Figure 5a ). However, due to their higher viable cell density, the specific glucose utilisation rate for Bcl-2 cell line was lower compared to control cell lines (Figure 5b ). The nutrients were used to generate new biomass (new cells) and/or used to maintain the cell survival of Bcl-2 cultures, and therefore less nutrients were used for product formation. Furthermore, at the active proliferation stage, the machinery of product formation may be temporarily shut down in the Bcl-2 cultures to provide more energy for biomass generation and for repair necessary to prevent death.
Another explanation for the low specific antibody production rate in the Bcl-2 cell line is the low antibody release rate of the cultures. The mechanism of antibody release can be through both secretion and passive release. 34 Antibodies in the healthy cells are only released from the cell through secretion. However, when the dying cells loss their membrane integrity, the antibodies stored in the intracellular vesicles are passively released from the cells. Indeed, Simpson et al. 15 have reported that the productivity of control cell line in batch culture was increased in association with the onset of cell death. The finding by Mohan et al. 35 that antibody heterogeneity increases toward the end of the batch culture of hybridoma cells provides further evidence of the passive release of incomplete glycosylated antibodies from the dead cells. Therefore, it is not surprising that the specific antibody productivity in the Bcl-2 culture was lower compared to the control culture since the viability for the Bcl-2 culture is very much higher. Feedback inhibition can be ruled out as an explanation for the reduction in antibody production but the productivity of this cell line has been shown to be substantially higher in optimized industrial condition with no demonstratable effect of feedback inhibition. Figure 6 shows the dissolved oxygen (DO) level for both cell lines during the perfusion culture. The DO level for batch cultures was initially set at 50% air saturation, and the culture was aerated with air via immersed silicone tubing. As the viable cell density in the Bcl-2 culture increased, air was insufficient to maintain the DO level at 50%, and therefore the culture was aerated with pure oxygen at day 8. Similarly, the control culture was aerated with pure oxygen from day 12 onwards. However, pure oxygen was also insufficient to meet the demand of the Bcl-2 culture due to the high cell density and therefore the DO dropped to about 20% at day 13 and remained at that level until the culture was terminated. The reductions in DO level to 20% from day 13 onwards in the Bcl-2 culture may have been associated with the reduced growth rate (Figure 2c ) and increased glucose utilisation rate (Figure 5b ).
Conclusion
Broadly speaking it is not clear that suppression of apoptosis via Bcl-2 over-expression offers an advantage for the manufacture of recombinant proteins. If the aims are purely to obtain the maximum product, then it shows that prolonging the culture longevity is not beneficial. On the other hand, if the aim is to achieve a homogeneous and complete glycosylated product, Bcl-2 over-expression may offer an advantage. Furthermore, suppression of cell death will prevent the release of intracellular protease as a result of the loss of membrane integrity, thereby reducing the degradation of secreted antibodies. The reduced level of cell debris and fragmented DNA would simplify clarification during the downstream process and the DNA concentration at the end product.
